Tag Archives: Rob Michelson

C3 Advocates Contribute to RFA Effectiveness Review

How useful is radiofrequency ablation (RFA) in treating liver metastases from colorectal cancer? To answer that question, American Society for Clinical Oncology scientists included two C3 advocates, Rob Michelson and Dr. Andrew Guisti, on an expert panel looking at published RFA research. In appreciation, the panel dedicated their Clinical Evidence Review to Michelson who died in January, 2008. The Expert Panel wishes to dedicate this Clinical Evidence Review to Rob Michelson, who served as the patient representative at the Panel meeting in October 2007 and passed away early in 2008. His contributions at the meeting and as a reviewer of the first draft were substantive and thought provoking.

Top